Recent results of management of palpable clinically localized prostate cancer

The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?.

International journal of radiation oncology, biology, physics·2001

Radiation oncology: contributions of the United States in the last years of the 20th century.

Radiology·2001

Impact of managed care on scholarly activity and patient care: case study of 12 academic radiology and radiation oncology departments.

Radiology·2000

Radiation oncology in the third millennium.

Rays·1999

Cost-benefit analysis of 3D conformal radiation therapy--treatment of prostate cancer as a model.

Acta oncologica (Stockholm, Sweden)·1999

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.

British journal of cancer·1999

Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025.

Cancer·2026

Progression-free survival and overall survival in the first-line treatment of BRCA wild-type advanced epithelial ovarian cancer: An analysis of patient-level data pooled from historical clinical trials.

Cancer·2026

Trends in sociodemographic factors associated with human papillomavirus vaccine hesitancy in the United States: 2010-2022.

Cancer·2026

External validation of the NADIR model for early prostate-specific antigen response prediction in enzalutamide-treated metastatic hormone-sensitive prostate cancer: An analysis of the ARCHES trial.

Cancer·2026

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Cancer·2026

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

Cancer·2026

USP26-mediated stabilization of RAD51 promotes endometrial cancer progression and limits ferroptosis.

Frontiers in oncology·2026

European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Radiomic model versus R.E.N.A.L. nephrometry score for predicting the likelihood of undergoing partial nephrectomy in clear cell renal cell carcinoma.

Frontiers in urology·2026

Lipid signature in X-ALD: a comparison between phenotypes.

Frontiers in molecular biosciences·2026

Pattern-Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy.

Cancer reports (Hoboken, N.J.)·2026

Oral glucocorticoid dose patterns and organ damage in systemic lupus erythematosus - a nationwide cohort study.

Arthritis & rheumatology (Hoboken, N.J.)·2026

Related Experiment Videos

Recent results of management of palpable clinically localized prostate cancer

Related Concept Videos

The rush to judgment: Does the evidence support the enthusiasm over three-dimensional conformal radiation therapy and dose escalation in the treatment of prostate cancer?.

Radiation oncology: contributions of the United States in the last years of the 20th century.

Impact of managed care on scholarly activity and patient care: case study of 12 academic radiology and radiation oncology departments.

Radiation oncology in the third millennium.

Cost-benefit analysis of 3D conformal radiation therapy--treatment of prostate cancer as a model.

G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.

Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025.

Progression-free survival and overall survival in the first-line treatment of BRCA wild-type advanced epithelial ovarian cancer: An analysis of patient-level data pooled from historical clinical trials.

Trends in sociodemographic factors associated with human papillomavirus vaccine hesitancy in the United States: 2010-2022.

External validation of the NADIR model for early prostate-specific antigen response prediction in enzalutamide-treated metastatic hormone-sensitive prostate cancer: An analysis of the ARCHES trial.

Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis.

Efficacy and safety of frail patients treated with ciltacabtagene autoleucel in the real world: A Center for International Blood and Marrow Transplant Research analysis.

USP26-mediated stabilization of RAD51 promotes endometrial cancer progression and limits ferroptosis.

European society for organ transplantation clinical practice guideline on prevention and treatment of chronic lung allograft dysfunction.

Radiomic model versus R.E.N.A.L. nephrometry score for predicting the likelihood of undergoing partial nephrectomy in clear cell renal cell carcinoma.

Lipid signature in X-ALD: a comparison between phenotypes.

Pattern-Based P53 Immunohistochemistry Predicts Recurrence in Colorectal Liver Metastases Without Complete Pathologic Response After Neoadjuvant Chemotherapy.

Oral glucocorticoid dose patterns and organ damage in systemic lupus erythematosus - a nationwide cohort study.

Related Experiment Videos

Recent results of management of palpable clinically localized prostate cancer

Related Concept Videos

Related Articles